(Q46079253)

19 December 2017

title

The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness (English)

1 reference

19 December 2017

author name string

R I G Holt

1

1 reference

19 December 2017

T Abdelrahman

2

1 reference

19 December 2017

M Hirsch

3

1 reference

19 December 2017

Z Dhesi

4

1 reference

19 December 2017

T George

5

1 reference

19 December 2017

T Blincoe

6

1 reference

19 December 2017

R C Peveler

7

1 reference

19 December 2017

language of work or name

English

0 references

publication date

20 March 2009

1 reference

19 December 2017

Journal of Psychopharmacology

published in

1 reference

19 December 2017

volume

24

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

page(s)

867-873

1 reference

19 December 2017

The metabolic syndrome--a new worldwide definition

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Consensus development conference on antipsychotic drugs and obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Cardiovascular disease risk profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

A UK audit of screening for the metabolic side effects of antipsychotics in community patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Causes of the excess mortality of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Quality of preventive medical care for patients with mental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Medical comorbidity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Prevalence of Metabolic Syndrome in Hispanic and Non-Hispanic Patients With Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Prevalence of the metabolic syndrome among patients receiving clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Impairment of health and quality of life in people with large waist circumference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Incidence of cancer among persons with schizophrenia and their relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

A comparison of gynecological variables and service use among older women with and without schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Mammography stages of change in middle-aged women with schizophrenia: an exploratory analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Prevalence of the metabolic syndrome in veterans with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Effect of Acute Psychotic Stress in Nondiabetic Subjects on β-Cell Function and Insulin Sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

A well-being programme in severe mental illness. Baseline findings in a UK cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

Dysglycemia in a community sample of people treated for schizophrenia: the Diabetes in Schizophrenia in Central-South Ontario (DiSCO) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102788

21 January 2018

Identifiers

DOI

10.1177/0269881109102788

1 reference

19 December 2017

PubMed ID

19304868

1 reference

19 December 2017